CoChat

An International Multicenter Randomized Controlled Trial of G17DT in Patients With Pancreatic Cancer

Gilliam, Andrew D., Broome, Paul, Topuzov, Eskender G., Garin, Avgust M., Pulay, Istvan, Humphreys, Jane, Whitehead, Anne, Takhar, Arjun, Rowlands, Brian J., Beckingham, Ian J. · 2012 · Pancreas
Cited by 89

The DOI matches its Crossref record.

Abstract

OBJECTIVES: This study aimed to investigate G17DT, an immunogen producing neutralizing antibodies against the tumor growth factors amidated and glycine-extended forms of gastrin-17, in the treatment of pancreatic cancer. METHODS: A randomized, double-blind, placebo-controlled, group-sequential multicenter trial of G17DT in patients with advanced pancreatic cancer unsuitable for or unwilling to take chemotherapy. Inclusion criteria were a Karnofsky performance score of 60 or higher and a life expectancy of more than 2 months. Patients received G17DT or placebo emulsion at weeks 0, 1, 3, 24, and 52. The primary end point was survival, and secondary end points were tolerability, Karnofsky performance. RESULTS: A total of 154 patients were recruited: 79 G17DT and 75 placebo. A final analysis of the intention-to-treat population, using a proportional hazards model, stratifying by disease stage and adjusting for interim analysis, gave a hazard ratio for mortality of 0.75 (95% confidence interval, 0.51-1.10, P = 0.138; G17DT/placebo). A conventional analysis without adjustment for disease stage or interim analysis, censoring for chemotherapy and excluding protocol violators, gave median survival periods of 151 (G17DT) and 82 days (placebo) (log-rank test, P = 0.03).Patients developing anti-G17DT responses (73.8%) survived longer than nonresponders or those on placebo (median survival, 176 vs 63 vs 83; log-rank test, P = 0.003). G17DT was well tolerated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mpa.0b013e31822ade7e

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 89

Metadata

Authors
Gilliam, A. D., Broome, P., Topuzov, E. G., Garin, A. M., Pulay, I., Humphreys, J., Whitehead, A., Takhar, A., Rowlands, B. J., & Beckingham, I. J.
Venue
Pancreas
Published
2012-04
Volume
41
Issue
3
Pages
374-379
ISSN
0885-3177 (ISSN-L)
OpenAlex
W2041329586
Cited by
89
References
0
FWCI
3.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An International Multicenter Randomized Controlled Trial of G17DT in Patients With Pancreatic Cancer. https://app.cochat.ai/papers/10.1097/mpa.0b013e31822ade7e
The paper
Gilliam, A. D., Broome, P., Topuzov, E. G., Garin, A. M., Pulay, I., Humphreys, J., Whitehead, A., Takhar, A., Rowlands, B. J., & Beckingham, I. J. (2012). An International Multicenter Randomized Controlled Trial of G17DT in Patients With Pancreatic Cancer. Pancreas. https://doi.org/10.1097/mpa.0b013e31822ade7e

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.